| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | antigen binding | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 SLC7A8 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 2.07e-14 | 190 | 139 | 17 | GO:0003823 |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 1.31e-06 | 28 | 139 | 5 | GO:0005251 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.25e-05 | 167 | 139 | 8 | GO:0015079 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 ABCC1 DDX12P UBA2 MCM6 MSH4 MORC4 DDX46 MOCS3 MYO3B ACSBG2 ATP1A2 ATP1A4 ATP4A DDX11L8 | 2.54e-05 | 614 | 139 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 3.82e-05 | 10 | 139 | 3 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 3.82e-05 | 10 | 139 | 3 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 5.23e-05 | 11 | 139 | 3 | GO:0008556 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 SLC26A3 SLC25A18 TUSC3 PKD1L1 KCNG3 SLC25A22 KCNA2 KCNA3 KCNA4 KCNA5 P2RX1 ATP1A2 ATP1A4 SLC23A2 ATP4A | 7.75e-05 | 758 | 139 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TUSC3 PKD1L1 KCNG3 KCNA2 KCNA3 KCNA4 KCNA5 P2RX1 ATP1A2 ATP1A4 SLC23A2 ATP4A | 1.02e-04 | 465 | 139 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | potassium ion binding | 1.14e-04 | 14 | 139 | 3 | GO:0030955 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC25A18 TUSC3 PKD1L1 KCNG3 SLC25A22 KCNA2 KCNA3 KCNA4 KCNA5 P2RX1 ATP1A2 ATP1A4 SLC23A2 ATP4A | 1.24e-04 | 627 | 139 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | 6-phosphofructokinase activity | 1.44e-04 | 3 | 139 | 2 | GO:0003872 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC1 SLC26A3 SLC25A18 SLC22A23 TUSC3 PKD1L1 KCNG3 SLC7A8 SLC25A22 KCNA2 KCNA3 KCNA4 KCNA5 P2RX1 MFSD14B SLC25A1 ATP1A2 ATP1A4 SLC23A2 ATP4A | 1.96e-04 | 1180 | 139 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC25A18 TUSC3 PKD1L1 KCNG3 SLC25A22 KCNA2 KCNA3 KCNA4 KCNA5 P2RX1 ATP1A2 ATP1A4 SLC23A2 ATP4A | 2.25e-04 | 664 | 139 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | transporter activity | ABCC1 SLC26A3 SLC25A18 SLC22A23 TUSC3 PKD1L1 KCNG3 PITPNM1 SLC7A8 SLC25A22 KCNA2 KCNA3 KCNA4 KCNA5 P2RX1 MFSD14B SLC25A1 ATP1A2 ATP1A4 SLC23A2 ATP4A | 2.30e-04 | 1289 | 139 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | DNA replication origin binding | 2.49e-04 | 18 | 139 | 3 | GO:0003688 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.65e-04 | 127 | 139 | 6 | GO:0016616 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 2.86e-04 | 4 | 139 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 2.95e-04 | 19 | 139 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 4.13e-04 | 138 | 139 | 6 | GO:0016614 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC26A3 SLC25A18 TUSC3 PKD1L1 KCNG3 SLC25A22 KCNA2 KCNA3 KCNA4 KCNA5 P2RX1 ATP1A2 ATP1A4 SLC23A2 ATP4A | 4.25e-04 | 793 | 139 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | fructose-6-phosphate binding | 4.75e-04 | 5 | 139 | 2 | GO:0070095 | |
| GeneOntologyMolecularFunction | hypotaurine monooxygenase activity | 4.75e-04 | 5 | 139 | 2 | GO:0047822 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 5.08e-04 | 94 | 139 | 5 | GO:0050660 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 6.25e-04 | 207 | 139 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 6.43e-04 | 208 | 139 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | N,N-dimethylaniline monooxygenase activity | 7.09e-04 | 6 | 139 | 2 | GO:0004499 | |
| GeneOntologyMolecularFunction | amino acid:proton symporter activity | 7.09e-04 | 6 | 139 | 2 | GO:0005280 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 7.20e-04 | 212 | 139 | 7 | GO:0017171 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 7.37e-04 | 102 | 139 | 5 | GO:0005249 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 7.63e-04 | 26 | 139 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 8.54e-04 | 27 | 139 | 3 | GO:0015271 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 9.87e-04 | 7 | 139 | 2 | GO:0005004 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 9.87e-04 | 7 | 139 | 2 | GO:0008443 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSPD1 ABCC1 DDX12P MCM6 MORC4 DDX46 ATP1A2 ATP1A4 ATP4A DDX11L8 | 1.06e-03 | 441 | 139 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 1.29e-03 | 31 | 139 | 3 | GO:0005310 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 SLC26A3 SLC25A18 SLC7A8 SLC25A22 SLC25A1 ATP1A2 ATP1A4 SLC23A2 ATP4A | 1.89e-03 | 477 | 139 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.99e-03 | 36 | 139 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.99e-03 | 36 | 139 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | potassium channel activity | 2.03e-03 | 128 | 139 | 5 | GO:0005267 | |
| GeneOntologyMolecularFunction | L-aspartate transmembrane transporter activity | 2.09e-03 | 10 | 139 | 2 | GO:0015183 | |
| GeneOntologyMolecularFunction | ubiquitin-like modifier activating enzyme activity | 2.09e-03 | 10 | 139 | 2 | GO:0008641 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 2.54e-03 | 11 | 139 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.70e-03 | 40 | 139 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 2.90e-03 | 41 | 139 | 3 | GO:0016877 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 3.31e-03 | 207 | 139 | 6 | GO:0008236 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 4.14e-03 | 14 | 139 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.25e-03 | 152 | 139 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 4.49e-03 | 293 | 139 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | C4-dicarboxylate transmembrane transporter activity | 4.76e-03 | 15 | 139 | 2 | GO:0015556 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 4.76e-03 | 15 | 139 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 4.76e-03 | 15 | 139 | 2 | GO:0005005 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | HSPD1 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 4.63e-13 | 235 | 140 | 17 | GO:0016064 |
| GeneOntologyBiologicalProcess | B cell mediated immunity | HSPD1 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 8.52e-13 | 244 | 140 | 17 | GO:0019724 |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | HSPD1 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 PNP IGHV3-66 | 1.60e-09 | 449 | 140 | 18 | GO:0002449 |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | HSPD1 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 LAT2 AZU1 IGHV3-74 IGHV3-73 IGHV3-72 PNP IGHV3-66 | 2.20e-09 | 576 | 140 | 20 | GO:0002443 |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | HSPD1 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 PNP IGHV3-66 | 2.50e-09 | 462 | 140 | 18 | GO:0002460 |
| GeneOntologyBiologicalProcess | immune effector process | HSPD1 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 LAT2 AZU1 CFD IGHV3-74 IGHV3-73 IGHV3-72 PNP IGHV3-66 | 3.49e-07 | 859 | 140 | 21 | GO:0002252 |
| GeneOntologyBiologicalProcess | adaptive immune response | HSPD1 IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 LAT2 CD7 IGHV3-74 IGHV3-73 IGHV3-72 PNP IGHV3-66 | 9.94e-07 | 838 | 140 | 20 | GO:0002250 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 3.02e-05 | 232 | 140 | 9 | GO:0071805 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 3.65e-05 | 91 | 140 | 6 | GO:0140115 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 4.85e-05 | 11 | 140 | 3 | GO:0010248 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 1.03e-04 | 272 | 140 | 9 | GO:0006813 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 1.13e-04 | 37 | 140 | 4 | GO:0055075 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.26e-04 | 163 | 140 | 7 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.47e-04 | 167 | 140 | 7 | GO:1903825 | |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 1.94e-04 | 17 | 140 | 3 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 1.94e-04 | 17 | 140 | 3 | GO:0036376 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 2.66e-04 | 46 | 140 | 4 | GO:0051938 | |
| GeneOntologyCellularComponent | immunoglobulin complex | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 2.19e-14 | 166 | 140 | 16 | GO:0019814 |
| GeneOntologyCellularComponent | presynaptic membrane | 1.07e-04 | 277 | 140 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | 6-phosphofructokinase complex | 1.33e-04 | 3 | 140 | 2 | GO:0005945 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 3.68e-04 | 91 | 140 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | synaptic membrane | ACHE SYT6 CSMD2 RPH3A CNTN6 CASK KCNA2 KCNA3 KCNA4 EFNB3 P2RX1 EPHA4 | 5.64e-04 | 583 | 140 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | potassium channel complex | 6.78e-04 | 104 | 140 | 5 | GO:0034705 | |
| Domain | K_chnl_volt-dep_Kv1 | 1.19e-07 | 8 | 122 | 4 | IPR003972 | |
| Domain | K_chnl_volt-dep_Kv | 7.88e-07 | 27 | 122 | 5 | IPR003968 | |
| Domain | VG_K_chnl | 2.25e-06 | 33 | 122 | 5 | IPR028325 | |
| Domain | P-type_ATPase_IIC | 5.36e-06 | 6 | 122 | 3 | IPR005775 | |
| Domain | - | 1.53e-05 | 169 | 122 | 8 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 1.81e-05 | 173 | 122 | 8 | IPR016040 | |
| Domain | BTB_2 | 2.45e-05 | 53 | 122 | 5 | PF02214 | |
| Domain | T1-type_BTB | 2.45e-05 | 53 | 122 | 5 | IPR003131 | |
| Domain | - | 3.21e-05 | 56 | 122 | 5 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 3.50e-05 | 57 | 122 | 5 | IPR023753 | |
| Domain | Channel_four-helix_dom | 3.50e-05 | 57 | 122 | 5 | IPR027359 | |
| Domain | - | 3.50e-05 | 57 | 122 | 5 | 1.20.120.350 | |
| Domain | 6-Pfructokinase_euk | 1.26e-04 | 3 | 122 | 2 | IPR009161 | |
| Domain | PHOSPHOFRUCTOKINASE | 1.26e-04 | 3 | 122 | 2 | PS00433 | |
| Domain | Phosphofructokinase_CS | 1.26e-04 | 3 | 122 | 2 | IPR015912 | |
| Domain | PFK | 1.26e-04 | 3 | 122 | 2 | PF00365 | |
| Domain | ATP_PFK | 1.26e-04 | 3 | 122 | 2 | IPR022953 | |
| Domain | Phosphofructokinase_dom | 1.26e-04 | 3 | 122 | 2 | IPR000023 | |
| Domain | ATPase_P-typ_TM_dom | 1.43e-04 | 16 | 122 | 3 | IPR023298 | |
| Domain | - | 1.43e-04 | 16 | 122 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.73e-04 | 17 | 122 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.73e-04 | 17 | 122 | 3 | PF00689 | |
| Domain | BTB | 1.81e-04 | 180 | 122 | 7 | SM00225 | |
| Domain | Cation_ATPase_N | 2.07e-04 | 18 | 122 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 2.07e-04 | 18 | 122 | 3 | SM00831 | |
| Domain | BTB/POZ_dom | 2.15e-04 | 185 | 122 | 7 | IPR000210 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.44e-04 | 19 | 122 | 3 | IPR004014 | |
| Domain | SKP1/BTB/POZ | 2.45e-04 | 189 | 122 | 7 | IPR011333 | |
| Domain | 3HC_DH_C | 2.52e-04 | 4 | 122 | 2 | IPR006108 | |
| Domain | 3HCDH | 2.52e-04 | 4 | 122 | 2 | PS00067 | |
| Domain | 3HCDH | 2.52e-04 | 4 | 122 | 2 | PF00725 | |
| Domain | 3-OHacyl-CoA_DH_NAD-bd | 2.52e-04 | 4 | 122 | 2 | IPR006176 | |
| Domain | 3-OHacyl-CoA_DH_CS | 2.52e-04 | 4 | 122 | 2 | IPR006180 | |
| Domain | 3HCDH_N | 2.52e-04 | 4 | 122 | 2 | PF02737 | |
| Domain | Flavin_mOase | 4.18e-04 | 5 | 122 | 2 | IPR000960 | |
| Domain | DiMe-aniline_mOase | 4.18e-04 | 5 | 122 | 2 | IPR012143 | |
| Domain | FMO-like | 4.18e-04 | 5 | 122 | 2 | PF00743 | |
| Domain | Flavin_mOase-like | 4.18e-04 | 5 | 122 | 2 | IPR020946 | |
| Domain | fn3 | 6.85e-04 | 162 | 122 | 6 | PF00041 | |
| Domain | Ion_trans_dom | 9.12e-04 | 114 | 122 | 5 | IPR005821 | |
| Domain | Ion_trans | 9.12e-04 | 114 | 122 | 5 | PF00520 | |
| Domain | - | 1.17e-03 | 32 | 122 | 3 | 3.40.1110.10 | |
| Domain | - | 1.17e-03 | 32 | 122 | 3 | 2.70.150.10 | |
| Domain | Mit_carrier | 1.17e-03 | 32 | 122 | 3 | IPR002067 | |
| Domain | FN3 | 1.36e-03 | 185 | 122 | 6 | SM00060 | |
| Domain | ATPase_P-typ_cyto_domN | 1.53e-03 | 35 | 122 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.66e-03 | 36 | 122 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.66e-03 | 36 | 122 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.66e-03 | 36 | 122 | 3 | PS00154 | |
| Domain | HAD-like_dom | 1.78e-03 | 79 | 122 | 4 | IPR023214 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.80e-03 | 37 | 122 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.80e-03 | 37 | 122 | 3 | PF00122 | |
| Domain | ThiF_NAD_FAD-bd | 1.84e-03 | 10 | 122 | 2 | IPR000594 | |
| Domain | ThiF | 1.84e-03 | 10 | 122 | 2 | PF00899 | |
| Domain | 6PGD_dom_2 | 1.84e-03 | 10 | 122 | 2 | IPR013328 | |
| Domain | - | 1.84e-03 | 10 | 122 | 2 | 1.10.1040.10 | |
| Domain | FN3 | 1.97e-03 | 199 | 122 | 6 | PS50853 | |
| Domain | FN3_dom | 2.52e-03 | 209 | 122 | 6 | IPR003961 | |
| Domain | FAD-dep_OxRdtase | 2.68e-03 | 12 | 122 | 2 | IPR006076 | |
| Domain | DAO | 2.68e-03 | 12 | 122 | 2 | PF01266 | |
| Domain | - | 5.02e-03 | 53 | 122 | 3 | 1.50.40.10 | |
| Domain | Mito_carr | 5.02e-03 | 53 | 122 | 3 | PF00153 | |
| Domain | SOLCAR | 5.02e-03 | 53 | 122 | 3 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 5.02e-03 | 53 | 122 | 3 | IPR018108 | |
| Domain | Mt_carrier_dom | 5.02e-03 | 53 | 122 | 3 | IPR023395 | |
| Domain | TRYPSIN_SER | 5.16e-03 | 106 | 122 | 4 | PS00135 | |
| Domain | TRYPSIN_HIS | 5.33e-03 | 107 | 122 | 4 | PS00134 | |
| Domain | Peptidase_S1A | 6.46e-03 | 113 | 122 | 4 | IPR001314 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 LAT2 IGHV3-74 IGHV3-66 | 4.56e-11 | 45 | 108 | 9 | MM14912 |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 1.81e-10 | 35 | 108 | 8 | MM17219 |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 CFD IGHV3-74 IGHV3-66 | 2.59e-10 | 54 | 108 | 9 | MM14655 |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 4.61e-10 | 39 | 108 | 8 | MM17212 |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 CD163 IGHV3-74 IGHV3-66 | 6.92e-10 | 60 | 108 | 9 | MM14872 |
| Pathway | REACTOME_FCGR_ACTIVATION | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 2.67e-09 | 48 | 108 | 8 | MM17214 |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 6.08e-09 | 53 | 108 | 8 | MM15716 |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 9.56e-09 | 56 | 108 | 8 | MM14815 |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 1.27e-08 | 58 | 108 | 8 | MM14914 |
| Pathway | REACTOME_COMPLEMENT_CASCADE | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 CFD IGHV3-74 IGHV3-66 | 1.48e-08 | 84 | 108 | 9 | MM14653 |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 1.68e-08 | 60 | 108 | 8 | MM14913 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 PROCR SLC7A8 IGHV3-74 IGHV3-66 | 3.55e-07 | 158 | 108 | 10 | MM14812 |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 ITGB7 IGHV3-74 IGHV3-66 | 9.10e-07 | 135 | 108 | 9 | MM14781 |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 1.59e-06 | 107 | 108 | 8 | MM14915 |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 LAT2 IGHV3-74 IGHV3-66 | 2.20e-06 | 150 | 108 | 9 | MM14889 |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 2.57e-06 | 114 | 108 | 8 | MM14814 |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 7.25e-06 | 131 | 108 | 8 | MM15717 |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 1.42e-05 | 69 | 108 | 6 | M27150 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.45e-05 | 41 | 108 | 5 | MM14546 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 1.68e-05 | 71 | 108 | 6 | M27203 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.84e-05 | 43 | 108 | 5 | M1056 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 3.34e-05 | 80 | 108 | 6 | M6121 | |
| Pathway | BIOCARTA_BARRESTIN_PATHWAY | 6.90e-05 | 11 | 108 | 3 | MM1501 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 7.53e-05 | 134 | 108 | 7 | M29840 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 8.79e-05 | 95 | 108 | 6 | M29842 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORTERS | 9.15e-05 | 12 | 108 | 3 | M27350 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORTERS | 9.15e-05 | 12 | 108 | 3 | MM15087 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 1.02e-04 | 61 | 108 | 5 | M27581 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.05e-04 | 98 | 108 | 6 | M27152 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 1.50e-04 | 14 | 108 | 3 | MM1489 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 1.80e-04 | 154 | 108 | 7 | M39007 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.83e-04 | 69 | 108 | 5 | M27108 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 2.09e-04 | 71 | 108 | 5 | M1078 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.52e-04 | 115 | 108 | 6 | M19752 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 2.75e-04 | 17 | 108 | 3 | MM1491 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 4.11e-04 | 82 | 108 | 5 | M27110 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 5.12e-04 | 86 | 108 | 5 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 5.12e-04 | 86 | 108 | 5 | M27206 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 5.40e-04 | 87 | 108 | 5 | M27205 | |
| Pathway | WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS | 5.73e-04 | 5 | 108 | 2 | M39449 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 6.41e-04 | 190 | 108 | 7 | M8240 | |
| Pathway | REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION | 6.93e-04 | 23 | 108 | 3 | M27174 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 7.25e-04 | 194 | 108 | 7 | M16312 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 9.28e-04 | 98 | 108 | 5 | MM14545 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 1.16e-03 | 103 | 108 | 5 | M1073 | |
| Pathway | REACTOME_HEMOSTASIS | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 PROCR SLC7A8 CFD P2RX1 IGHV3-74 IGHV3-66 | 1.40e-03 | 571 | 108 | 12 | MM14472 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.43e-03 | 108 | 108 | 5 | M823 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.47e-03 | 219 | 108 | 7 | M29836 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.49e-03 | 109 | 108 | 5 | MM15074 | |
| Pathway | REACTOME_PARASITE_INFECTION | 1.97e-03 | 116 | 108 | 5 | M29843 | |
| Pathway | WP_STEROID_BIOSYNTHESIS | 2.02e-03 | 9 | 108 | 2 | MM15903 | |
| Pathway | REACTOME_MALATE_ASPARTATE_SHUTTLE | 2.02e-03 | 9 | 108 | 2 | M48269 | |
| Pathway | REACTOME_MALATE_ASPARTATE_SHUTTLE | 2.02e-03 | 9 | 108 | 2 | MM17242 | |
| Pathway | WP_STEROID_BIOSYNTHESIS | 2.51e-03 | 10 | 108 | 2 | M39538 | |
| Pubmed | The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 1.52e-18 | 91 | 142 | 14 | 9841928 |
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 3.91e-16 | 77 | 142 | 12 | 15608191 |
| Pubmed | 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization. | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 3.97e-16 | 15 | 142 | 8 | 12657787 |
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 1.93e-14 | 22 | 142 | 8 | 2499654 |
| Pubmed | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-9 IGHV3-7 | 4.66e-14 | 39 | 142 | 9 | 8490662 | |
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 6296789 | ||
| Pubmed | A biological consequence of variation in the site of D-JH gene rearrangement. | 2.66e-10 | 4 | 142 | 4 | 6434992 | |
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 19428559 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 106394 | ||
| Pubmed | Somatic evolution of diversity among anti-phosphocholine antibodies induced with Proteus morganii. | 2.66e-10 | 4 | 142 | 4 | 3106498 | |
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 6769593 | ||
| Pubmed | Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus. | 2.66e-10 | 4 | 142 | 4 | 25127856 | |
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 8750831 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 10449099 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 3135325 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 25157256 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 8046334 | ||
| Pubmed | Structure of the T15 VH gene subfamily: identification of immunoglobulin gene promotor homologies. | 2.66e-10 | 4 | 142 | 4 | 3108392 | |
| Pubmed | The D segment defines the T15 idiotype: the immunoresponse of A/J mice to Pneumococcus pneumoniae. | 2.66e-10 | 4 | 142 | 4 | 6499907 | |
| Pubmed | Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins. | 2.66e-10 | 4 | 142 | 4 | 819932 | |
| Pubmed | Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice. | 2.66e-10 | 4 | 142 | 4 | 3104790 | |
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 2005389 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 12734355 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 2748602 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 21068211 | ||
| Pubmed | Antibody diversity: somatic hypermutation of rearranged VH genes. | 2.66e-10 | 4 | 142 | 4 | 6101208 | |
| Pubmed | Sequence and fine specificity analysis of primary 511 anti-phosphorylcholine antibodies. | 2.66e-10 | 4 | 142 | 4 | 2512348 | |
| Pubmed | Developmentally controlled expression of immunoglobulin VH genes. | 2.66e-10 | 4 | 142 | 4 | 3975629 | |
| Pubmed | IgD+IgM- B cells mount immune responses that exhibit altered antibody repertoire. | 1.33e-09 | 5 | 142 | 4 | 14991595 | |
| Pubmed | 1.33e-09 | 5 | 142 | 4 | 24324757 | ||
| Pubmed | 1.33e-09 | 5 | 142 | 4 | 10367906 | ||
| Pubmed | 1.33e-09 | 5 | 142 | 4 | 401950 | ||
| Pubmed | 1.84e-08 | 8 | 142 | 4 | 12435606 | ||
| Pubmed | 5.49e-08 | 10 | 142 | 4 | 3396540 | ||
| Pubmed | Developmental expression of voltage-sensitive K+ channels in mouse skeletal muscle and C2C12 cells. | 5.49e-08 | 10 | 142 | 4 | 1383027 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 1986382 | ||
| Pubmed | 6.20e-07 | 40 | 142 | 5 | 16382104 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 11149959 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 10428084 | ||
| Pubmed | 7.80e-07 | 18 | 142 | 4 | 6788376 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 3036582 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 8938729 | ||
| Pubmed | Physical mapping of potassium channel gene clusters on mouse chromosomes three and six. | 1.32e-06 | 6 | 142 | 3 | 9286706 | |
| Pubmed | Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly. | 1.32e-06 | 6 | 142 | 3 | 14686897 | |
| Pubmed | CAPN9 KLK11 SMURF1 SEMA3G KCNG3 KHSRP CFD KCNA2 KCNA3 KCNA4 KCNA5 ATP1A2 ATP4A DNASE2 | 1.93e-06 | 730 | 142 | 14 | 34857952 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 7477295 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 9852577 | ||
| Pubmed | HSPD1 RBBP5 UBA2 MCM6 LRRC59 PFKM CASK INTS14 MOCS3 HADHA GFM1 SDHA | 3.53e-06 | 560 | 142 | 12 | 35241646 | |
| Pubmed | 3.71e-06 | 26 | 142 | 4 | 7905852 | ||
| Pubmed | HSPD1 IGHV3-49 ADCY4 IGHV3-15 RBP3 SMURF1 LRRC59 PFKM PFKP RPH3A KHSRP CASK PITPNM1 SLC25A22 HADHA ATP1A2 SDHA IGHV3-73 IGHV3-72 | 6.21e-06 | 1431 | 142 | 19 | 37142655 | |
| Pubmed | Proteomic analysis of the mouse liver mitochondrial inner membrane. | 8.13e-06 | 175 | 142 | 7 | 12865426 | |
| Pubmed | SCRAPPER-dependent ubiquitination of active zone protein RIM1 regulates synaptic vesicle release. | 1.43e-05 | 12 | 142 | 3 | 17803915 | |
| Pubmed | EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract. | 1.66e-05 | 2 | 142 | 2 | 9789074 | |
| Pubmed | Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages. | 1.66e-05 | 2 | 142 | 2 | 17157812 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 11182083 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 2822475 | ||
| Pubmed | Expression and chromosomal localization of a lymphocyte K+ channel gene. | 1.66e-05 | 2 | 142 | 2 | 2251283 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12815189 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 10555956 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12383247 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 29874189 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22360360 | ||
| Pubmed | Development and reorganization of corticospinal projections in EphA4 deficient mice. | 1.66e-05 | 2 | 142 | 2 | 11438928 | |
| Pubmed | Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus. | 1.66e-05 | 2 | 142 | 2 | 20798505 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 38890684 | ||
| Pubmed | Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. | 1.66e-05 | 2 | 142 | 2 | 17038323 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16729292 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 31597447 | ||
| Pubmed | An epilepsy-associated KV1.2 charge-transfer-center mutation impairs KV1.2 and KV1.4 trafficking. | 1.66e-05 | 2 | 142 | 2 | 35439054 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 11897791 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 17544406 | ||
| Pubmed | Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations. | 1.66e-05 | 2 | 142 | 2 | 25985179 | |
| Pubmed | Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle. | 1.66e-05 | 2 | 142 | 2 | 2001794 | |
| Pubmed | N-glycans modulate K(v)1.5 gating but have no effect on K(v)1.4 gating. | 1.66e-05 | 2 | 142 | 2 | 19961828 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 18948148 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 4522793 | ||
| Pubmed | Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. | 1.66e-05 | 2 | 142 | 2 | 12850541 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22876132 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.40e-05 | 139 | 142 | 6 | 16985003 | |
| Pubmed | 3.16e-05 | 146 | 142 | 6 | 29509794 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | HSPD1 AZU1 UBA2 MCM6 OSGEP PFKM PFKP KHSRP CASK FBXO22 ARAP3 SMS GFM1 SDHA | 4.84e-05 | 974 | 142 | 14 | 28675297 |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 33141153 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 26931497 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11182082 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11551524 | ||
| Pubmed | Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues. | 4.95e-05 | 3 | 142 | 2 | 156693 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 7825568 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 6451249 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 2276745 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11389904 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 14699416 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 10428758 | ||
| Pubmed | The effects of Eph-ephrin mutations on pre-pulse inhibition in mice. | 4.95e-05 | 3 | 142 | 2 | 24949848 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 33669857 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 8994044 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 6444721 | ||
| Pubmed | Ephrin-B3, a ligand for the receptor EphB3, expressed at the midline of the developing neural tube. | 4.95e-05 | 3 | 142 | 2 | 9484836 | |
| Pubmed | The scaffolding protein CASK mediates the interaction between rabphilin3a and beta-neurexins. | 4.95e-05 | 3 | 142 | 2 | 11377421 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11137296 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 24682423 | ||
| Interaction | CPD interactions | 2.32e-06 | 175 | 132 | 9 | int:CPD | |
| Interaction | PDE12 interactions | 3.02e-06 | 135 | 132 | 8 | int:PDE12 | |
| Interaction | DLG1 interactions | 4.17e-06 | 240 | 132 | 10 | int:DLG1 | |
| Interaction | ATP1A1 interactions | HSPD1 NTRK1 LRRC59 PFKP RHOU CFD FBXO22 KCNA3 TRIM67 SLC25A1 HADHA ATP1A2 ATP1A4 ATP4A SDHA | 5.61e-06 | 575 | 132 | 15 | int:ATP1A1 |
| Interaction | EPHX1 interactions | 6.27e-06 | 106 | 132 | 7 | int:EPHX1 | |
| Interaction | SSC4D interactions | 1.11e-05 | 45 | 132 | 5 | int:SSC4D | |
| Interaction | PLOD3 interactions | 2.80e-05 | 183 | 132 | 8 | int:PLOD3 | |
| Interaction | VANGL2 interactions | 3.03e-05 | 185 | 132 | 8 | int:VANGL2 | |
| Interaction | FERMT2 interactions | 3.53e-05 | 189 | 132 | 8 | int:FERMT2 | |
| Interaction | TMLHE interactions | 3.88e-05 | 58 | 132 | 5 | int:TMLHE | |
| Interaction | PFKM interactions | 4.09e-05 | 193 | 132 | 8 | int:PFKM | |
| Interaction | ME3 interactions | 4.36e-05 | 11 | 132 | 3 | int:ME3 | |
| Interaction | NDUFS1 interactions | HSPD1 NTRK1 LRRC59 PFKM RHOU CFD TRIM67 SLC25A1 HADHA GFM1 SDHA | 4.49e-05 | 383 | 132 | 11 | int:NDUFS1 |
| Interaction | KCNA5 interactions | 4.57e-05 | 60 | 132 | 5 | int:KCNA5 | |
| Interaction | STT3B interactions | 4.88e-05 | 256 | 132 | 9 | int:STT3B | |
| Interaction | UBA6 interactions | 5.96e-05 | 150 | 132 | 7 | int:UBA6 | |
| Interaction | TAOK3 interactions | 6.25e-05 | 64 | 132 | 5 | int:TAOK3 | |
| Interaction | LMAN2 interactions | 6.67e-05 | 105 | 132 | 6 | int:LMAN2 | |
| Interaction | KCNA4 interactions | 8.37e-05 | 68 | 132 | 5 | int:KCNA4 | |
| Interaction | EMC2 interactions | HSPD1 NTRK1 LRRC59 ERGIC2 PFKM RHOU CFD DDX46 TRIM67 HADHA SDHA | 8.45e-05 | 411 | 132 | 11 | int:EMC2 |
| Interaction | USP6NL interactions | 8.64e-05 | 110 | 132 | 6 | int:USP6NL | |
| Interaction | OSBPL8 interactions | 8.70e-05 | 276 | 132 | 9 | int:OSBPL8 | |
| Interaction | LARS2 interactions | 9.31e-05 | 161 | 132 | 7 | int:LARS2 | |
| Interaction | ALDH16A1 interactions | 9.61e-05 | 70 | 132 | 5 | int:ALDH16A1 | |
| Interaction | CASK interactions | 1.06e-04 | 221 | 132 | 8 | int:CASK | |
| Interaction | QTRT1 interactions | 1.09e-04 | 38 | 132 | 4 | int:QTRT1 | |
| Interaction | SRPRA interactions | 1.14e-04 | 286 | 132 | 9 | int:SRPRA | |
| Interaction | IGHV3-7 interactions | 1.27e-04 | 3 | 132 | 2 | int:IGHV3-7 | |
| Interaction | NT5DC2 interactions | 1.27e-04 | 118 | 132 | 6 | int:NT5DC2 | |
| Interaction | SLC25A18 interactions | 1.34e-04 | 40 | 132 | 4 | int:SLC25A18 | |
| Interaction | EIF2AK4 interactions | 1.51e-04 | 77 | 132 | 5 | int:EIF2AK4 | |
| Interaction | ALCAM interactions | 1.51e-04 | 77 | 132 | 5 | int:ALCAM | |
| Interaction | GANAB interactions | 1.58e-04 | 368 | 132 | 10 | int:GANAB | |
| Interaction | REXO2 interactions | 1.62e-04 | 42 | 132 | 4 | int:REXO2 | |
| Interaction | IDH2 interactions | 1.71e-04 | 237 | 132 | 8 | int:IDH2 | |
| Interaction | GAB1 interactions | 1.74e-04 | 178 | 132 | 7 | int:GAB1 | |
| Interaction | LETM1 interactions | 1.76e-04 | 238 | 132 | 8 | int:LETM1 | |
| Interaction | KIFBP interactions | 1.86e-04 | 180 | 132 | 7 | int:KIFBP | |
| Interaction | SEC24B interactions | 1.86e-04 | 240 | 132 | 8 | int:SEC24B | |
| Interaction | ETFA interactions | 2.03e-04 | 309 | 132 | 9 | int:ETFA | |
| Interaction | ATE1 interactions | 2.04e-04 | 82 | 132 | 5 | int:ATE1 | |
| Interaction | SARS1 interactions | 2.07e-04 | 129 | 132 | 6 | int:SARS1 | |
| Interaction | RABL6 interactions | 2.16e-04 | 130 | 132 | 6 | int:RABL6 | |
| Interaction | C9orf78 interactions | HSPD1 RBBP5 SMURF1 UBA2 MCM6 LRRC59 PFKM CASK INTS14 MOCS3 HADHA GFM1 SDHA | 2.20e-04 | 620 | 132 | 13 | int:C9orf78 |
| Interaction | ELAC2 interactions | 2.28e-04 | 186 | 132 | 7 | int:ELAC2 | |
| Interaction | UNC5B interactions | 2.28e-04 | 84 | 132 | 5 | int:UNC5B | |
| Interaction | ERO1A interactions | 2.35e-04 | 132 | 132 | 6 | int:ERO1A | |
| Interaction | POFUT2 interactions | 2.46e-04 | 19 | 132 | 3 | int:POFUT2 | |
| Interaction | MAN2B1 interactions | 2.54e-04 | 86 | 132 | 5 | int:MAN2B1 | |
| Interaction | RAB10 interactions | 2.59e-04 | 190 | 132 | 7 | int:RAB10 | |
| Interaction | FADS1 interactions | 2.69e-04 | 87 | 132 | 5 | int:FADS1 | |
| Interaction | MAP4K4 interactions | 2.74e-04 | 254 | 132 | 8 | int:MAP4K4 | |
| Interaction | ASS1 interactions | 2.76e-04 | 192 | 132 | 7 | int:ASS1 | |
| Interaction | SLC12A2 interactions | 3.03e-04 | 195 | 132 | 7 | int:SLC12A2 | |
| Interaction | PDIA6 interactions | 3.09e-04 | 327 | 132 | 9 | int:PDIA6 | |
| Interaction | ME2 interactions | 3.14e-04 | 90 | 132 | 5 | int:ME2 | |
| Interaction | MORC2 interactions | 3.31e-04 | 91 | 132 | 5 | int:MORC2 | |
| Interaction | HSD3B2 interactions | 3.35e-04 | 21 | 132 | 3 | int:HSD3B2 | |
| Interaction | NPLOC4 interactions | 3.43e-04 | 199 | 132 | 7 | int:NPLOC4 | |
| Interaction | LAMB1 interactions | 3.48e-04 | 142 | 132 | 6 | int:LAMB1 | |
| Interaction | CTNND1 interactions | 3.64e-04 | 265 | 132 | 8 | int:CTNND1 | |
| Interaction | ERBIN interactions | 3.64e-04 | 265 | 132 | 8 | int:ERBIN | |
| Cytoband | 14q32.33 | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 2.51e-17 | 228 | 142 | 16 | 14q32.33 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 3.13e-10 | 566 | 142 | 15 | chr14q32 |
| Cytoband | 1q42.11-q42.3 | 9.50e-06 | 2 | 142 | 2 | 1q42.11-q42.3 | |
| Cytoband | 19p13.3 | 8.87e-04 | 237 | 142 | 5 | 19p13.3 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 1.08e-14 | 187 | 104 | 16 | 349 |
| GeneFamily | Potassium voltage-gated channels | 3.21e-06 | 40 | 104 | 5 | 274 | |
| GeneFamily | Fibronectin type III domain containing | 3.25e-04 | 160 | 104 | 6 | 555 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 6.75e-04 | 7 | 104 | 2 | 1208 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.43e-03 | 10 | 104 | 2 | 100 | |
| GeneFamily | Kallikreins | 3.73e-03 | 16 | 104 | 2 | 616 | |
| Coexpression | XU_CREBBP_TARGETS_DN | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 EPHA4 IGHV3-66 | 1.37e-11 | 56 | 137 | 9 | MM642 |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 CFD CRYL1 IGHV3-74 IGHV3-66 | 1.55e-10 | 102 | 137 | 10 | MM872 |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 4.84e-07 | 132 | 137 | 8 | MM996 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 2.67e-05 | 165 | 137 | 7 | M8121 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | IGHV3-48 TRIM15 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 | 2.02e-08 | 183 | 132 | 11 | Arv_SC-HD_1000_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | TNK1 IGHV3-48 TRIM15 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 SPRED3 IGHV3-74 IGHV3-66 | 1.07e-07 | 266 | 132 | 12 | Arv_SC-hpx_blastocyst_1000_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5 | IGHV3-48 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 | 2.22e-07 | 183 | 132 | 10 | Arv_SC_fibroblast_1000_K5 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4 | IGHV3-48 TRIM15 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 SPRED3 IGHV3-74 IGHV3-66 | 3.75e-07 | 244 | 132 | 11 | Arv_SC-H9hpx_1000_K4 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2 | IGHV3-48 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-66 | 8.40e-07 | 163 | 132 | 9 | Arv_SC-hpx_blastocyst_500_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3 | IGHV3-48 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-66 | 1.52e-06 | 175 | 132 | 9 | Arv_SC-H9hpx_500_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2 | IGHV3-48 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-72 | 1.40e-05 | 126 | 132 | 7 | Arv_SC-HD_500_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_2500_k-means-cluster#4 | TNK1 IGHV3-48 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 SPRED3 IGSF9 IGHV3-74 IGHV3-66 | 1.45e-05 | 426 | 132 | 12 | Arv_SC-hpx_blastocyst_2500_K4 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_2500_k-means-cluster#2 | TNK1 IGHV3-48 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 SPRED3 IGSF9 IGHV3-74 IGHV3-66 | 1.52e-05 | 428 | 132 | 12 | Arv_SC-H9hpx_2500_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3 | IGHV3-48 SLC26A3 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-72 | 2.64e-05 | 139 | 132 | 7 | Arv_SC_fibroblast_500_K3 |
| CoexpressionAtlas | PP_HSC_top-relative-expression-ranked_2500_k-means-cluster#2 | DMGDH IGHV3-48 IGHV3-15 IGHV3-9 IGHV3-7 EML4 KLK12 ERGIC2 IGHV3-66 | 2.02e-04 | 325 | 132 | 9 | PP_HSC_2500_K2 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-7 TROAP IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 2.36e-15 | 194 | 142 | 14 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-9 IGHV3-7 LRRC59 IGHV3-74 IGHV3-72 IGHV3-66 | 7.25e-14 | 196 | 142 | 13 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 LAT2 ITGB7 IGHV3-74 IGHV3-72 IGHV3-66 | 7.74e-14 | 197 | 142 | 13 | 2662138671262b30508c5759038bcdcfe6551696 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-7 SEMA3G IGHV3-74 IGHV3-72 | 6.02e-13 | 179 | 142 | 12 | 837ed81f18257f444eaeadc4fac89deedd4e3061 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-7 SEMA3G IGHV3-74 IGHV3-72 | 6.02e-13 | 179 | 142 | 12 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 1.22e-12 | 190 | 142 | 12 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 1.22e-12 | 190 | 142 | 12 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-13 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 | 1.47e-12 | 193 | 142 | 12 | 7b4b0271e4fbece703876acb053ae236afb7cdba |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 ITGB7 IGHV3-74 IGHV3-72 IGHV3-66 | 1.47e-12 | 193 | 142 | 12 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 IGHV3-66 | 1.66e-12 | 195 | 142 | 12 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGHV3-53 IGHV3-35 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-9 IGHV3-7 SEMA3G IGHV3-74 IGHV3-73 IGHV3-72 | 2.47e-12 | 152 | 142 | 11 | a2ba2d95ac9010e1a62db34dcad10d004f8a90cc |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-7 SEMA3G IGHV3-74 | 1.30e-11 | 177 | 142 | 11 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-7 SEMA3G IGHV3-74 | 1.30e-11 | 177 | 142 | 11 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-7 SEMA3G IGHV3-74 | 1.30e-11 | 177 | 142 | 11 | fc40918825b7e1eb6861df59dfca944778a64b98 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 ICAM3 ITGB7 CTHRC1 IGHV3-66 | 1.98e-11 | 184 | 142 | 11 | 15f2c10101ccc8ed059520fc082ee42593dff269 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 ICAM3 ITGB7 CTHRC1 IGHV3-66 | 1.98e-11 | 184 | 142 | 11 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-7 SEMA3G IGHV3-74 IGHV3-66 | 2.50e-11 | 188 | 142 | 11 | bd53b0371154cff680226897b61c9809a239d1b6 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 | 3.32e-11 | 193 | 142 | 11 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 PKD1L1 ITGB7 IGHV3-72 | 3.71e-11 | 195 | 142 | 11 | df009b18898c10686f75cf72b4ec0eff18f5bb50 |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 | 3.92e-11 | 196 | 142 | 11 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 ICAM3 CTHRC1 IGHV3-73 | 2.33e-10 | 173 | 142 | 10 | 0ca2169a275404118038c0489a48062879488765 |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-9 IGHV3-7 SEMA3G IGHV3-74 | 2.76e-10 | 176 | 142 | 10 | 4b4416f342b732d2cc60133838728880326257d8 |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-9 IGHV3-7 SEMA3G IGHV3-74 | 2.76e-10 | 176 | 142 | 10 | d895a6b295cd649273ff80ad7785a3e0ae4c728a |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 KCNA3 CTHRC1 IGHV3-74 IGHV3-72 | 2.92e-10 | 177 | 142 | 10 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 KCNA3 CTHRC1 IGHV3-74 IGHV3-72 | 2.92e-10 | 177 | 142 | 10 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-7 SEMA3G IGHV3-72 | 3.26e-10 | 179 | 142 | 10 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-66 | 3.63e-10 | 181 | 142 | 10 | e47664a264a2c37390d1668ce04eef2e0172f4cb |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 4.50e-10 | 185 | 142 | 10 | 08bc817908076734d66f2805cb954141f2cc5a18 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 4.50e-10 | 185 | 142 | 10 | 1704a12153a9b107bf03ecccd1a036cf61334d7a |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 TROAP ITGB7 IGHV3-74 IGHV3-72 IGHV3-66 | 5.26e-10 | 188 | 142 | 10 | 6844cebca177fdf38b21a40d606230a033717a3a |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 LAT2 IGHV3-74 IGHV3-66 | 7.14e-10 | 194 | 142 | 10 | a4a70369541876e1192df8828b63e3d1746ae3d9 |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-72 IGHV3-66 | 3.52e-09 | 167 | 142 | 9 | f2185eb72f0137136f6d71af2a70168fded6c940 |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-72 IGHV3-66 | 3.52e-09 | 167 | 142 | 9 | 5e768cf24699893e05d1bcb1c92dba2336943a64 |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-15 CTHRC1 IGHV3-74 IGHV3-66 | 5.31e-09 | 175 | 142 | 9 | 51301f3f44d3e88397f367cedd1e2abaa2be4c6f |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 6.16e-09 | 178 | 142 | 9 | 107dae8b00c4257697a63700e72bb434cdb8406f |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 ICAM3 ITGB7 CTHRC1 IGHV3-66 | 6.79e-09 | 180 | 142 | 9 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 7.85e-09 | 183 | 142 | 9 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 LAT2 KMO | 8.63e-09 | 185 | 142 | 9 | 0fa7970709dc957dea95fabbd83263a0335babd5 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 ITGB7 CD7 IGHV3-74 IGHV3-72 | 1.14e-08 | 191 | 142 | 9 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-74 IGHV3-66 | 1.36e-08 | 195 | 142 | 9 | 2d18f08f33f3b261c77b8adf87d1a184cc6d7400 |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-72 IGHV3-66 | 1.36e-08 | 195 | 142 | 9 | d0305c6a68c9e361507b04db94f86873085d49b3 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 | 1.42e-08 | 196 | 142 | 9 | fec21383435779bf4c632decd3d29c6ca7baebfb |
| ToppCell | Biopsy_Control_(H.)-Immune-Plasma_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | IGHV3-53 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-7 ITGB7 IGHV3-66 | 1.49e-08 | 197 | 142 | 9 | 275f38ed7e477000e864cecf9b7d49ae134c3b6a |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 | 1.49e-08 | 197 | 142 | 9 | 1e63879633f20646e44873ae6b662f6faf4806fd |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 LAT2 IGHV3-74 IGHV3-72 IGHV3-66 | 1.49e-08 | 197 | 142 | 9 | da175e66d0a743a1b91d46f224b5ff1d37aa5410 |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-49 IGHV3-23 IGHV3-21 KMO KCNA2 KCNA3 P2RX1 CTHRC1 IGHV3-74 | 1.70e-08 | 200 | 142 | 9 | e1b3fc516887510b18cf688ada0e00b5f5eff684 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGHV3-53 IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-16 DEFA4 IGHV3-74 IGHV3-66 | 6.39e-08 | 166 | 142 | 8 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | IGHV3-53 IGHV3-23 IGHV3-15 IGHV3-13 IGHV3-7 P2RX1 IGHV3-73 IGHV3-72 | 7.34e-08 | 169 | 142 | 8 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-7 ICAM3 P2RX1 IGHV3-66 | 1.00e-07 | 176 | 142 | 8 | 50e207403d48ce1b55a78897adb5519a2430a626 |
| ToppCell | -IPF_03|World / lung cells shred on cell class, cell subclass, sample id | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 IGHV3-7 ITGB7 | 1.05e-07 | 177 | 142 | 8 | ae2d2e138946535596fa30a55207f261cafda461 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-07 | 178 | 142 | 8 | 34ef4d36ddfb1cdeaaaf5d952e1ad6dc2785ce1e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-53 IGHV3-23 IGHV3-21 IGHV3-15 KCNA3 IGHV3-73 IGHV3-72 IGHV3-66 | 1.19e-07 | 180 | 142 | 8 | e3877f6ef5f54ff689058b4c996ab1851822f871 |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-07 | 180 | 142 | 8 | 1c5515f29ead129bee3b4ca27799796956811a39 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-13 ICAM3 P2RX1 CTHRC1 IGHV3-72 | 1.30e-07 | 182 | 142 | 8 | 1bf2e4fd6222b41a7d08df6dcc500c9401db8c18 |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 ICAM3 P2RX1 CTHRC1 | 1.67e-07 | 188 | 142 | 8 | 33360f1c30315d9772731c9067834dc059172b79 |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma|bone_marrow / Manually curated celltypes from each tissue | IGHV3-53 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 CTHRC1 IGHV3-74 IGHV3-72 | 1.73e-07 | 189 | 142 | 8 | dceb011216deb4ffd830144a53c635c05dff5ec5 |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 ICAM3 P2RX1 CTHRC1 | 1.88e-07 | 191 | 142 | 8 | 17746a32f723c078aba1f7e320b0e3f1ab8bf5c6 |
| ToppCell | cellseq2-Immune-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 ICAM3 P2RX1 CTHRC1 | 1.88e-07 | 191 | 142 | 8 | c2c450df810f83163987cd0f7ed9b50025cd3de1 |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-48 IGHV3-21 IGHV3-15 ICAM3 ITGB7 P2RX1 IGHV3-74 IGHV3-66 | 1.96e-07 | 192 | 142 | 8 | ca4d8e540d9e6fa47ecf97648cbd5abfc7ab7f85 |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 ICAM3 KCNA3 P2RX1 IGHV3-74 | 2.20e-07 | 195 | 142 | 8 | 0b0615553b9a1b60d666d074ce4260919e2d5642 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-72 IGHV3-66 | 2.20e-07 | 195 | 142 | 8 | 13f4ee21568fd747608412d33559d10561dbb3c8 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-7 IGHV3-72 IGHV3-66 | 2.29e-07 | 196 | 142 | 8 | c38e7f533c619afe008de0e99042f7180c2da918 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-48 IGHV3-38 IGHV3-23 IGHV3-15 IGHV3-13 P2RX1 IGHV3-74 IGHV3-66 | 2.29e-07 | 196 | 142 | 8 | b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 LAT2 IGHV3-74 IGHV3-66 | 2.38e-07 | 197 | 142 | 8 | 0e56255862fed099e771ebd2529393dc5a3641ba |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-66 | 2.38e-07 | 197 | 142 | 8 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | Sigmoid-T_cell-CD8_T|T_cell / Region, Cell class and subclass | IGHV3-53 IGHV3-49 IGHV3-48 IGHV3-21 IGHV3-15 IGHV3-7 CD7 IGHV3-74 | 2.67e-07 | 200 | 142 | 8 | 2071a71b6fba403f55becddc0434d56a0b598c8e |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.75e-07 | 142 | 142 | 7 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.38e-07 | 157 | 142 | 7 | 554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.38e-07 | 157 | 142 | 7 | 2cb3deb5313ce734710c601935ca318e4179077e | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.12e-06 | 167 | 142 | 7 | afb6d0993f3fd44a295874673055189d514f7b11 | |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-06 | 173 | 142 | 7 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGHV3-48 IGHV3-23 IGHV3-16 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 | 1.41e-06 | 173 | 142 | 7 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 174 | 142 | 7 | fa6eb451555766398996bbe8f555a3f4c0f3c108 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 174 | 142 | 7 | 1f5b0fa58b2a7335667357af7e50e5242cd13d7d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 174 | 142 | 7 | ac3aee6ed49d1c421f33509e3ffc5cb17750a473 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 175 | 142 | 7 | c36b4526970db9ccfbe2c70b00961fab9f13b133 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 175 | 142 | 7 | c1e082538f31b5c98ac63f71dcca4a1211a14708 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-06 | 175 | 142 | 7 | c3d3f11602379aaba65842a98835299e54fccd84 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 175 | 142 | 7 | 2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce | |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-16 IGHV3-15 IGHV3-7 | 1.53e-06 | 175 | 142 | 7 | d73ee324479172501481b54967a0f3bd870fcf3a |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-72 IGHV3-66 | 1.65e-06 | 177 | 142 | 7 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | 1.65e-06 | 177 | 142 | 7 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 | |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | 1.65e-06 | 177 | 142 | 7 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGHV3-53 IGHV3-49 IGHV3-23 IGHV3-13 IGHV3-7 IGHV3-72 IGHV3-66 | 1.84e-06 | 180 | 142 | 7 | 6a777a308fa3160d31eda468db930e71862020b2 |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.91e-06 | 181 | 142 | 7 | f7b08f662eb77ee7a777c6525ddc3195046aaf65 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-7 IGHV3-73 IGHV3-66 | 2.06e-06 | 183 | 142 | 7 | dea119e2988e954475f557f0bbe12556a83e81a4 |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | IGHV3-48 IGHV3-23 IGHV3-15 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 | 2.13e-06 | 184 | 142 | 7 | 6f70d8f8ab8362d51f8a58735d42223e06566397 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 | 2.21e-06 | 185 | 142 | 7 | 0fff2608f507e019ebb69c27e58fd5be3b049bef |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-13 IGHV3-7 IGHV3-74 | 2.21e-06 | 185 | 142 | 7 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma|Liver / Manually curated celltypes from each tissue | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-7 IGHV3-74 IGHV3-73 IGHV3-72 | 2.29e-06 | 186 | 142 | 7 | a2c7430781f432c9c90ac4d620f4518ff767a223 |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-21 IGHV3-7 IGHV3-73 IGHV3-66 | 2.29e-06 | 186 | 142 | 7 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 2.46e-06 | 188 | 142 | 7 | c7b1807c96f87fbcd37739a159cf00f9a1ff5d71 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.55e-06 | 189 | 142 | 7 | 5a42be62552d912d0abf68f00d75ac80bbd69f2c | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-06 | 190 | 142 | 7 | e1af324b4522045875fb64766cf118cd7b41704a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-06 | 191 | 142 | 7 | 8c35fccc4617694eae1e55b1107841ffe7f1bac8 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-06 | 193 | 142 | 7 | 5c5543e7c83ecea44d23521246592c0301044173 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.92e-06 | 193 | 142 | 7 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.92e-06 | 193 | 142 | 7 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.35e-06 | 197 | 142 | 7 | 365654a344bfdd2533cfcbed05063427b40f47b9 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.35e-06 | 197 | 142 | 7 | 9936dc179aa0cf8aadf77946b26c09ad33848dc2 | |
| Computational | Xenobiotic metabolism. | 1.04e-05 | 37 | 86 | 5 | MODULE_247 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 3.23e-06 | 7 | 135 | 3 | DOID:0060178 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.06e-05 | 163 | 135 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 2.00e-05 | 12 | 135 | 3 | DOID:863 (implicated_via_orthology) | |
| Disease | cysteinylglycine measurement | 6.21e-05 | 3 | 135 | 2 | EFO_0800133 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 6.21e-05 | 3 | 135 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | glycogen storage disease (implicated_via_orthology) | 1.24e-04 | 4 | 135 | 2 | DOID:2747 (implicated_via_orthology) | |
| Disease | malaria (is_marker_for) | 3.08e-04 | 6 | 135 | 2 | DOID:12365 (is_marker_for) | |
| Disease | Hirschsprung's disease (is_marker_for) | 3.08e-04 | 6 | 135 | 2 | DOID:10487 (is_marker_for) | |
| Disease | Galloway Mowat syndrome | 5.71e-04 | 8 | 135 | 2 | C0795949 | |
| Disease | hemoglobin A1 measurement | 6.73e-04 | 520 | 135 | 9 | EFO_0007629 | |
| Disease | kallikrein-11 measurement | 7.32e-04 | 9 | 135 | 2 | EFO_0010573 | |
| Disease | octanoylcarnitine measurement | 7.32e-04 | 9 | 135 | 2 | EFO_0021042 | |
| Disease | overweight body mass index status | 1.11e-03 | 11 | 135 | 2 | EFO_0005935 | |
| Disease | obsolete_red blood cell distribution width | ABCC1 TRIM15 KLHL24 ISCA1 RBBP5 NTRK1 SLC22A23 MCM6 SLFN14 MIDEAS SLC7A8 KCNA4 MFSD14B FBXL20 SLC23A2 | 1.31e-03 | 1347 | 135 | 15 | EFO_0005192 |
| Disease | kallikrein-12 measurement | 1.57e-03 | 13 | 135 | 2 | EFO_0008194 | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 1.57e-03 | 13 | 135 | 2 | EFO_0010617 | |
| Disease | complement factor H-related protein 1 measurement | 2.17e-03 | 56 | 135 | 3 | EFO_0600054 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.39e-03 | 16 | 135 | 2 | C0393706 | |
| Disease | Liver Cirrhosis, Experimental | 3.03e-03 | 774 | 135 | 10 | C0023893 | |
| Disease | skin hydration measurement | 4.12e-03 | 21 | 135 | 2 | EFO_0009586 | |
| Disease | disease of metabolism (implicated_via_orthology) | 4.12e-03 | 21 | 135 | 2 | DOID:0014667 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TAVGAILAGGLCVGI | 121 | Q5FVE4 | |
| GGTGGNDTELVACLR | 291 | P22303 | |
| IIAGVAVGIFLCTGG | 221 | Q9UNN8 | |
| VGGHLCGTLAGCVRV | 411 | Q6PJG6 | |
| GLGLGVACVLARTQI | 191 | P09564 | |
| QIIIFSEALGGGVRG | 386 | Q86VW2 | |
| GIGICFIELQGCSVR | 431 | Q8WWN8 | |
| CGGTVRGEVSGQVLS | 1271 | Q7Z408 | |
| SVEGLCEGIGAGLVD | 196 | Q96CG8 | |
| CLVTGAGGFLGQRII | 6 | P14060 | |
| ALLGCGRVAIGGQSD | 296 | P43353 | |
| VRLCGIVGGIFSTTG | 316 | Q96RQ1 | |
| RVGVHSGSVLCGVIG | 366 | Q8NFM4 | |
| AVEEGIVLGGGCALL | 431 | P10809 | |
| VVGAGLQEVLGRGAL | 101 | Q8N1I8 | |
| GCSVQCGGGERRTIV | 811 | Q8TE56 | |
| CGLVLNGQGGVIRRG | 186 | Q7Z6R9 | |
| NGQGGVIRRGGTCVV | 191 | Q7Z6R9 | |
| GRILGGVCVVSGIVL | 386 | Q8TAE7 | |
| LGICEFGEQQGLLGV | 136 | Q0D2K2 | |
| GLVSACGIIVGNIIG | 41 | Q9UHI5 | |
| CGIIVGNIIGSGIFV | 46 | Q9UHI5 | |
| GVLEGVVTSGSRVCG | 216 | P00746 | |
| GEIGCDRIVTGNFIL | 361 | Q8NEZ5 | |
| TGVIIVGLQGEAERG | 2051 | Q96JQ0 | |
| AIQLGESGLVAGGRV | 166 | O14936 | |
| GEGTSLRGDINVCIV | 381 | Q14566 | |
| VGVKVGVRTRGCNGL | 46 | Q9BUE6 | |
| CLVGQGLVVKIGDFG | 656 | P04629 | |
| GVQCEVQLVESGGGL | 16 | A0A0C4DH42 | |
| GVQCEVQLVESGGGL | 16 | A0A0B4J1Y9 | |
| GGKIVGSLCAIAGVL | 386 | P16389 | |
| RVLVVGLGNSGCDIA | 186 | P31513 | |
| GVQCEVQLVESGGGL | 16 | A0A0B4J1V0 | |
| QVGLFEGTSLRCGGV | 36 | Q9UKR0 | |
| LFGVAGGLVACRVTE | 256 | Q96AG4 | |
| GVQCEVQLVESGGGL | 16 | P01780 | |
| GVQCEVQLVESGGGL | 16 | A0A0C4DH36 | |
| GVQCEVQLVESGGGL | 16 | P01782 | |
| VLVAVCGVEGGVRGL | 101 | Q8N0U4 | |
| CGVEGGVRGLDGLQV | 106 | Q8N0U4 | |
| GVQCEVQLVESGGGL | 16 | P01766 | |
| VIGVGEFGEVCSGRL | 626 | P54764 | |
| GVQCEVQLVESGGGL | 16 | P01763 | |
| VGQFIARAVGDGILC | 261 | Q53EL6 | |
| VGCGIQIGFFVSLVG | 96 | Q8NHB1 | |
| VGCGIQIGLFVCLVG | 96 | Q96R30 | |
| VKRGITNLCVIGGDG | 106 | P08237 | |
| QRGITNLCVIGGDGS | 116 | Q01813 | |
| RVLVIGLGNTGGDIA | 186 | P31512 | |
| KLINGGIAGLIGVTC | 11 | Q9H936 | |
| GGKIVGSLCAIAGVL | 456 | P22001 | |
| GLVGGETRIIKGFEC | 46 | Q9UBX7 | |
| GVQCEVQLVESGGGL | 16 | A0A0B4J1X5 | |
| RRGILELAGTVGCVG | 41 | O15496 | |
| GVQCEVQLVESGGGL | 16 | A0A0A0MS15 | |
| EALIVGGVGCNVRLQ | 256 | Q9NPF4 | |
| GVQCEVQLVESGGGL | 16 | A0A0B4J1V1 | |
| GLVENGVILFVVGCR | 46 | Q9Y5Y4 | |
| IALVLGGGGARGCAQ | 926 | Q6ZV29 | |
| GTLLAVGCNDGRIVI | 36 | Q15291 | |
| QEGAREIVCNVTLGG | 286 | P32942 | |
| AIVLGCVGGIVAVGL | 726 | P26010 | |
| CVGGIVAVGLGLVLA | 731 | P26010 | |
| GGEQISAIGRGICVL | 16 | Q8TEA8 | |
| ELGGLGERVLGFCQL | 541 | P50993 | |
| VGGKIVGSLCAIAGV | 491 | P22460 | |
| VVVGGCERVGGFNLP | 316 | Q6TFL4 | |
| VAVIGGGLVGSLQAC | 11 | O15229 | |
| QGEEQRGGGTLCAQL | 316 | O00115 | |
| KLINGGVAGLVGVTC | 11 | Q9H1K4 | |
| QGDRLLQVDGVILCG | 996 | Q68DX3 | |
| TEGRVDVLVCNAGLG | 81 | P14061 | |
| VVLVTDGCLGIGRGS | 111 | Q96SY0 | |
| RILCNLCGVVSGGVV | 691 | A8MPP1 | |
| EVGRILCNLCGVVSG | 706 | Q92771 | |
| GIAGLRCTNIGGLEL | 96 | P56746 | |
| TVSVREGQGVVLLCG | 131 | Q9UQ52 | |
| GVQCEVQLVESGGGL | 16 | P01764 | |
| ETVIIGGGCVGVSLA | 51 | Q9UI17 | |
| AVSTGDCGQVLRGGV | 436 | Q6PJG2 | |
| INGSCLGGGLEVAIS | 141 | P40939 | |
| AGCVVIVGSGVIGRS | 6 | Q9Y2S2 | |
| GGVRAGLCGQALLLT | 331 | Q5BKX5 | |
| IIGLGTFERGVGCLD | 356 | Q9HC35 | |
| TLGLRVVCVYGGTGI | 471 | Q7L014 | |
| KGLQGCLSTIEIGGI | 1091 | P82279 | |
| GVQCEVQLVESGGGL | 16 | A0A0C4DH30 | |
| RGGGSRCAGTVEVEI | 376 | Q86VB7 | |
| LGGATRTDICQGELG | 81 | O14815 | |
| CTGVLTRRGGICNGD | 186 | P20160 | |
| GVILFGRLGDLGTCQ | 46 | Q5W0N0 | |
| ELRVGNCLIGGVSFT | 76 | P12838 | |
| RVLDGAVLVLCAVGG | 136 | Q96RP9 | |
| EGLESLQGGVCLTRG | 146 | Q15768 | |
| QVAIICGSGLGGLTD | 26 | P00491 | |
| GRVERELTCLQGGLG | 1906 | Q8TDX9 | |
| CQRLGAIVAVTGDGV | 716 | P20648 | |
| TVSVREGQGVVLLCG | 131 | Q9P232 | |
| GVAQGIITGIRGLCN | 376 | Q5SR56 | |
| DGGVLGVVTGVLGCL | 241 | O95396 | |
| GVQCEVQLVETGGGL | 16 | P01767 | |
| GVQCEVQLVESGGGL | 16 | A0A0C4DH35 | |
| GVQCEVQLVESGGGL | 16 | A0A0B4J1V6 | |
| DGGGLSGKCSLVVRV | 321 | Q9Y5E3 | |
| GALVAVVGQVGCGKS | 671 | P33527 | |
| AQQEGIGGLCRGDLS | 151 | Q9GZY6 | |
| GSGIGIFGVATVLCD | 336 | P51575 | |
| CGLVIGRGGENVKAI | 436 | Q92945 | |
| IIGVCRVGITAEGLG | 461 | Q5T7P8 | |
| VGTRNGSILCDQIGG | 646 | O75445 | |
| VEICRINIDLTAGGG | 61 | O94941 | |
| ILGGGDGGILCEIVK | 196 | P52788 | |
| IGGCQLGISAKGERL | 651 | Q9Y2J0 | |
| IRAICALLNSGGGVI | 46 | P0C7P3 | |
| LITEGCRGEGGILIN | 306 | P31040 | |
| CRGEGGILINSQGER | 311 | P31040 | |
| VIRCGGLGLVLASAG | 566 | A1A5C7 | |
| GIQALVRGCGGLKAL | 186 | Q96IG2 | |
| GEGVGVIGVIECNFL | 356 | Q8TE76 | |
| LVVGAGGIGCELLKN | 21 | Q9UBT2 | |
| LGRGTNTEEGIGICY | 761 | O15457 | |
| IALGLGNIVCGVFRG | 376 | P40879 | |
| AVVGGIDGRLCLGGQ | 921 | Q9BVR0 | |
| GQVCLITGAGSGLGR | 36 | Q8IZV5 | |
| IVKNGRRICGTGGCL | 41 | Q5W111 | |
| DRIGTGGSVVDCRGL | 141 | Q9HCE7 | |
| CQRLGAVVAVTGDGV | 711 | Q13733 | |
| RAGGAEGRGVKCVLV | 41 | Q7L0Q8 | |
| EGRGVKCVLVGDGAV | 46 | Q7L0Q8 | |
| RVEGAVSLLVGGQVG | 351 | Q9Y3P4 | |
| CGQVALIGDGVGGIL | 556 | O00562 | |
| GGVCKGATVGVLLDL | 711 | Q6ZTA4 | |
| GDVGKRRIICLVGLG | 306 | Q13454 | |
| LGRALVIGEVTSGGC | 1161 | P10745 | |
| VEGLSCVLDGIFGTG | 421 | Q9UGH3 | |
| EGSVRLVGGANLCQG | 186 | Q8WTU2 | |
| LVGGANLCQGRVEIL | 191 | Q8WTU2 | |
| VGGGGLSQVSVCRVR | 21 | Q2MJR0 | |
| GGCTVGVAGEGVRRK | 361 | Q9C019 | |
| LLRQEVEGLVGGQCV | 441 | Q12815 | |
| STRGLLCGLGAGVAE | 121 | P53007 | |
| LCGLGAGVAEAVVVV | 126 | P53007 | |
| LAGVVGGVCFLGVAV | 736 | Q9P2J2 | |
| TVVGGGELGIACTLA | 186 | Q8IX04 | |
| VCRGELLGSGCFGVV | 116 | Q13470 | |
| VGRVCVNDAGGQRVL | 266 | Q9NS98 | |
| GLALCGQTLVVRGGS | 6 | P57081 | |
| VAGQSVAIEGGVCRL | 401 | Q9H6P5 | |
| GGKIVGSLCAIAGVL | 536 | P22459 | |
| GGSVTELVKGLLRCG | 111 | Q8WXR4 |